[{"id":"7bf35929-12d7-4980-addf-673178a01848","acronym":"CAR4SAR","url":"https://clinicaltrials.gov/study/NCT06087341","created_at":"2023-10-17T15:12:54.468Z","updated_at":"2024-07-02T16:35:09.876Z","phase":"Phase 1","brief_title":"A Phase I Trial of Memory T Cells Expressing an NKG2D Chimeric Antigen Receptor in Children, Adolescents and Young Adults With Advanced Sarcoma","source_id_and_acronym":"NCT06087341 - CAR4SAR","lead_sponsor":"Antonio Pérez Martínez","biomarkers":" NKG2D • ULBP2","pipe":"","alterations":" ","tags":["NKG2D • ULBP2"],"overall_status":"Recruiting","enrollment":" Enrollment 18","initiation":"Initiation: 01/10/2024","start_date":" 01/10/2024","primary_txt":" Primary completion: 01/01/2028","primary_completion_date":" 01/01/2028","study_txt":" Completion: 04/01/2028","study_completion_date":" 04/01/2028","last_update_posted":"2024-04-12"},{"id":"e1789d3b-7f73-4e03-8844-1658c55f879a","acronym":"","url":"https://clinicaltrials.gov/study/NCT01704274","created_at":"2021-01-18T07:25:02.274Z","updated_at":"2024-07-02T16:35:23.730Z","phase":"Phase 2","brief_title":"GTN Therapy on Biomarkers of Immune Escape in Men With Biochemical Recurrence of Prostate Cancer After Primary Therapy","source_id_and_acronym":"NCT01704274","lead_sponsor":"Dr. D. Robert Siemens","biomarkers":" PD-L1 • TGFB1 • ULBP2","pipe":"","alterations":" ","tags":["PD-L1 • TGFB1 • ULBP2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e nitroglycerin"],"overall_status":"Completed","enrollment":" Enrollment 43","initiation":"Initiation: 04/01/2012","start_date":" 04/01/2012","primary_txt":" Primary completion: 01/01/2017","primary_completion_date":" 01/01/2017","study_txt":" Completion: 12/01/2019","study_completion_date":" 12/01/2019","last_update_posted":"2024-01-11"}]